Navio provides healthcare providers with early access to treatment timelines for malignant brain tumors, enhancing patient management and experience. The company also offers a free app for patients and caregivers to effectively track and manage treatment processes.
Funding
$25.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing malignant brain tumors is complex, requiring coordinated care and timely access to treatment information. Healthcare providers often lack efficient tools to visualize and communicate treatment timelines, leading to potential delays and suboptimal patient management. Patients and caregivers also struggle to navigate the complexities of brain tumor treatment, impacting their ability to actively participate in care decisions.
Solution
Navio aims to provide a platform for healthcare providers to access and visualize treatment timelines for patients with malignant brain tumors, facilitating proactive patient management. The company intends to offer tools that enable clinicians to anticipate key decision points, coordinate care more effectively, and improve communication with patients. Navio also plans to provide a mobile application for patients and caregivers, designed to help them track appointments, manage medications, and access educational resources, thereby empowering them to navigate the treatment process.
Target Audience
The primary target audience includes healthcare providers involved in the care of patients with malignant brain tumors, as well as patients and their caregivers.
Features
- Visualization of treatment timelines for malignant brain tumors
- Tools for healthcare providers to anticipate key decision points in patient care
- Mobile application for patients and caregivers to track appointments and manage medications
- Educational resources for patients and caregivers to better understand brain tumor treatment